ELISA Microplate Drug Screening System

What is the ELISA Microplate Drug Screening System?

An ELISA microplate drug screening system uses antibody-coated 96-well plates, a washer and a plate reader to screen large batches for specific drugs or classes. It gives quantitative-range results and suits hair, urine and blood screening.

Overview

In a competitive ELISA, sample drug and an enzyme-conjugated drug compete for antibody binding sites in the wells. After incubation and washing, a substrate is added and the color developed is measured at 450 nm, inversely proportional to drug concentration. A system includes a microplate washer, incubator and reader, with automated workstations available for liquid handling. A 96-well plate screens about 80 samples plus calibrators and controls in around two hours. Sensitivity is high, which helps for hair and blood samples with low drug levels, and kits exist for opiates, cocaine, amphetamines, benzodiazepines and new psychoactive substances. Semi-quantitative results are read against a calibration curve, but cross-reactivity and matrix effects require verification and confirmation by mass spectrometry.

How does it work?

Most drug screening relies on competitive immunoassay. A labeled drug or drug-conjugate competes with drug in the sample for a limited number of antibody binding sites, so the signal is inversely related to the drug concentration. In lateral flow cassettes, the sample migrates along a nitrocellulose membrane and a colored line appears in the test region when drug is absent or below the cutoff. Readers use a camera or photodiode to interpret line intensity and remove visual subjectivity. Instrument immunoassays use enzyme-labeled or particle-enhanced reactions measured photometrically, and ELISA plates measure enzyme-generated color in wells with a microplate reader. Each assay is set to a cutoff concentration, for example 300 or 50 ng/mL depending on the drug, and results are presumptive until confirmed by GC-MS or LC-MS/MS.

What are the key features?

• 96-well competitive ELISA with antibody-coated plates
• Screens about 80 samples per plate in around two hours
• High sensitivity suited to hair and blood matrices
• Semi-quantitative results from calibration curves
• Microplate washer and reader integration options

What are the technical specifications?

A typical elisa microplate drug screening system configuration offers plate format of 96-well, samples per plate of approx. 80, assay time of approx. 2 h, reader wavelength of 450 nm (reference 620–650 nm), reader range of 0–4.0 OD and sample volume of 10–50 µL. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The ELISA Microplate Drug Screening System is used in hair drug screening, post-mortem blood screening, batch screening in forensic laboratories and new psychoactive substance screening. Across the wider Drug Screening Systems class, laboratories also deploy it for workplace drug testing programs, clinical and emergency department screening and drug treatment and probation monitoring.

Which standards and certifications apply?

Relevant standards and methods include ISO 15189, CLSI EP12, ISO 18113-1, IEC 61010-2-101 and SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing Programs. Certification candidates for this model are CE and ISO 9001 manufacturing; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Follow the manufacturer instructions for specimen collection, volume and read time, because reading outside the window can change the result. Store reagents and cassettes within the labeled temperature range and do not use them after expiry. Run positive and negative controls at defined intervals and record lot numbers. Maintain chain-of-custody and specimen integrity checks such as temperature, creatinine and adulterant testing for urine. Clean readers and optical windows, and verify calibration as specified. Because results are presumptive, define a confirmation pathway with a qualified laboratory and communicate cross-reactivity limits to reviewers. Keep personal data secure according to privacy rules applicable to testing programs.

How do I select the right ELISA Microplate Drug Screening System?

Choose ELISA for batch screening where sensitivity and a flexible panel matter, for example hair or blood. Automated analyzers suit higher daily volumes. In an RFQ, specify the plate format, reader wavelengths, washer type, target drug kits and any workstation automation.

How does it compare with other Drug Screening Systems variants?

Choose according to testing volume, setting and required evidence. Low-volume sites such as clinics and clubs often use instant cassettes or cups with a reader, while a central laboratory screening hundreds of samples a day needs an automated immunoassay analyzer. Oral fluid systems suit roadside and workplace testing where observed collection matters, and hair testing offers a long detection window. Check the drug panel, cutoff values, specimen types and cross-reactivity data. A reader reduces subjectivity and supports record-keeping, which is important for workplace programs. Consider connectivity with LIS or case management software, the cost of consumables, reagent stability and storage conditions. Programs following regulated guidelines must confirm that cutoffs and procedures match the required scheme.